Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
As a group, sell-side analysts forecast that Zimmer Biomet Holdings, Inc. will post 7.04 earnings per share for the current fiscal year.
Finally, TheStreet raised shares of Zimmer Biomet from a “c” rating to a “b” rating in a report on Tuesday, May 2nd.
First Hawaiian Bank’s holdings in Zimmer Biomet were worth $788,000 as of its most recent SEC filing.
Loop Capital boosted their price objective on Zimmer Biomet from $125.00 to $140.00 in a research report on Monday, February 6th.
Morgan Stanley reissued an “equal weight” rating and set a $140.00 price objective on shares of Zimmer Biomet in a research report on Wednesday, August 2nd.
Price T Rowe Associates Inc. MD increased its position in Zimmer Biomet by 13.5% during the 2nd quarter.
Ronald Blue Trust Inc. bought a new stake in Zimmer Biomet in the second quarter worth about $37,000.
Royal Bank of Canada raised their price target on shares of Zimmer Biomet from $141.00 to $156.00 in a report on Wednesday, May 3rd.
Vanguard Personalized Indexing Management LLC grew its holdings in Zimmer Biomet by 14.6% in the 2nd quarter.